GLI1 and melanoma: More recently, a pharmacophore-based virtual screening approach identified quinolines and oxazino-quinoline derivatives as small molecule GLI1 inhibitors characterized by submicromolar antiproliferative activity toward human melanoma and medulloblastoma cell lines [51,52].